Stock WNT WNTRESEARCH AB
Add to a list
To use this feature you must be a member
Log inSign up

All News WntResearch AB

Equities

WNT

SE0022239901

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 23:00:00 06/06/2024 BST 		5-day change 1st Jan Change
10.3 SEK +1.48% Intraday chart for WntResearch AB -0.58% +11.96%
05-03 WntResearch AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02-29 WntResearch AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
WntResearch : Presentationen från AGM.
PU
WntResearch's CEO to BioStock: "If the effect is confirmed, there are good opportunities for licensing agreements next year"
AQ
WntResearch AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
BioStock: WntResearch's new CEO comments on his first month in the position
AQ
Resigning WntResearch CEO tells BioStock: "It will be exciting to follow!"
AQ
WntResearch AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
WntResearch AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
WntResearch initiates collaboration with Business Sweden with the goal of establishing commercial partnerships for Foxy-5 in Japan and South Korea
AQ
WntResearch Initiates Collaboration with Business Sweden with the Goal of Establishing Commercial Partnerships for Foxy-5 in Japan and South Korea
CI
WntResearch continues to the next step in the phase 2 study NeoFox with the highest evaluated dose of Foxy-5
AQ
WntResearch AB Continues to the Next Step in the Phase 2 Study Neofox with the Highest Evaluated Dose of Foxy-5
CI
WntResearch announces the last day for trading in BTU and the first day for trading in warrants series TO 7 and warrants series TO 8
AQ
WntResearch carries out a directed issue of units to underwriters in connection with the completed rights issue
AQ
WntResearch publishes outcome in rights issue
AQ
WntResearch's co-founder applies for subscription of additional units in the ongoing rights issue with a last day for subscription on 29 January 2024
AQ
WntResearch Announces CEO Changes
CI
WntResearch publishes prospectus in connection with rights issue
AQ
Bulletin from the extraordinary general meeting in Wntresearch AB on 22 December 2023
AQ
WntResearch continues to the second dose group in clinical proof of concept study of Foxy-5
AQ
WntResearch Continues to the Second Dose Group in Clinical Proof of Concept Study of Foxy-5
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. WNT Stock
  4. News WntResearch AB
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW